Targeting Advanced ER+ Metastatic Breast Cancer with CDK 4/6 Inhibitors - Clinical Considerations and Emerging Opportunities

Registration is complimentary
Available seating will be based on room capacity. Seating is limited and pre-registration does not guarantee admission, as the room may be overbooked. Early arrival is recommended and seating will be first come first serve until capacity is met.
Online registration for this event has closed.
Please register onsite.
Event management software by Aventri